Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BTIG Maintains Buy on Aura Biosciences, Lowers Price Target to $21

Author: Benzinga Newsdesk | December 08, 2023 01:43pm
BTIG analyst Robert Hazlett maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $38 to $21.

Posted In: AURA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist